Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Eris Lifesciences acquires nine Glenmark Pharmaceuticals dermatology brands in INR340.48 crore deal Eris Lifesciences’ ₹340.48 crore purchase of nine Glenmark Pharmaceuticals dermatology brands reshapes India’s pharma market. See how it impacts strategy and growth. byPallavi MadhirajuJanuary 18, 2023